During the past decade, Lata Mangeshkar Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lata Mangeshkar Hospital" are "Human Immunodeficiency Virus Infections" (1 trials) and "Mycoses" (1 trials). Many other conditions were trialed in "Lata Mangeshkar Hospital" in a lesser frequency.

Most popular intervention types in "Lata Mangeshkar Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Itraconazole" (1 trials), "Rilpivirine 25 mg" (1 trials) and "Tenofovir Disoproxil Fumarate (TDF)/Lamivudine (3TC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lata Mangeshkar Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lata Mangeshkar Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Lata Mangeshkar Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lata Mangeshkar Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".